Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost et al.|JNCI Journal of the National Cancer Institute|2013Cited by 946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate CancerElena Castro, Rosalind A. Eeles, Chee Goh et al.|Journal of Clinical Oncology|2013Cited by 833
Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)Nadine Andrieu, Jenny Chang‐Claude, David E. Goldgar et al.|JNCI Journal of the National Cancer Institute|2006Cited by 233
Tamoxifen and Risk of Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersKelly‐Anne Phillips, John L. Hopper, Mary Beth Terry et al.|Journal of Clinical Oncology|2013Cited by 171
Mammographic Density and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersGillian Mitchell, Douglas F. Easton, Antonis C. Antoniou et al.|Cancer Research|2006Cited by 134